Hepatitis C virus infection, Linxian, China

Emerging Infectious Diseases

Volumn 11, Issue 1, 2005, Pages 17-21

  Zhang, Mingdong ^a   Sun, Xiu Di ^b   Mark, Steven D ^a   Chen, Wen ^b   Wong, Lara ^a   Dawsey, Sanford M ^a   Qiao, You Lin ^b   Fraumeni Jr , Joseph F ^a   Taylor, Philip R ^a   O'Brien, Thomas R ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CANCER HOSPITAL   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHINA; CONFERENCE PAPER; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE;

EID: 19944427383     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1101.031005     Document Type: Conference Paper

References (27)

1. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6:35-47.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20:1-16.
3. Thomas DL. Hepatitis C. Epidemiologic quandaries. Clin Liver Dis. 2001;5:955-68.
4. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B,C, D, and E virus infections in China, 1992. International Hepatology Communications. 1996;5:62-73.
5. Shimbo S, Zhang ZW, Gao WP, Hu ZH, Qu JB, Watanabe T, et al. Prevalence of hepatitis B and C infection markers among adult women in urban and rural areas in Shaanxi Province, China. Southeast Asian J Trop Med Public Health. 1998;29:263-8.
6. Zhang ZW, Shimbo S, Qu JB, Liu ZM, Cai XC, Wang LQ, et al. Hepatitis B and C virus infection among adult women in Jilin Province, China: an urban-rural comparison in prevalence of infection markers. Southeast Asian J Trop Med Public Health. 2000;31:530-6.
7. Qu JB, Zhang ZW, Shimbo S, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, et al. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci. 2000;13:243-53.
8. Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346:61-2.
9. Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan. 2001;16:41-6.
10. Rosenthal E. In rural China, a steep price of poverty: dying of AIDS. New York Times, October 28, 2000. p. 1.
11. Li B, Taylor PR, Li JY, Dawsey SM, Wang W, Tangrea JA, et al. Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol. 1993;3:577-85.
12. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology. 2000;32:388-93.
13. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: A community-based study in West Bengal, India. Hepatology. 2003;37:802-9.
14. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology. 1997;25:1490-6.
15. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-62.
16. Arthur RR, Hassan NF, Abdallah MY, el-Sharkawy MS, Saad MD, Hackbart BG, et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg. 1997;91:271-4.
17. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887-91.
18. Medhat A, Shehata M, Magder LS, Mikhail N, Abdel-Baki L, Nafeh M, et al. Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg. 2002;66:633-8.
19. Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol. 2001;65:30-4.
20. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002;62(Suppl) 1:8-17.
21. Di Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J Med Virol. 2002;67:339-44.
22. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2003;33:1-7.
23. Hao W, Xiao S, Liu T, Young D, Chen S, Zhang D, et al. The second National Epidemiological Survey on illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns. Addiction. 2002;97:1305-15.
24. Sun YD, Meng ZD, Wang SY, Chen XR, Sun DG, Chen Z, et al. Epidemiologic investigation on an outbreak of hepatitis C. Chin Med J (Engl), 1991;104:975-9.
25. Meng ZD, Sun YD, Chen XR, Wang SY, Sun DG, Chen Z, et al. A serological study of hepatitis C infection in plasmapheresis donors. Chin Med J (Engl). 1991;104:494-7.
26. Sun Z, Ming L, Zhu X, Lu J. Prevention and control of hepatitis B in China. J Med Virol. 2002;67:447-50.
27. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75:347-54.